Boston Scientific [BSX] vs Medtronic plc [MDT] Detailed Stock Comparison

Boston Scientific

NYSE

Medtronic plc

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Boston Scientific wins in 8 metrics, Medtronic plc wins in 11 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Boston Scientific	Medtronic plc	Better
P/E Ratio (TTM)	62.74	24.75	Medtronic plc
Price-to-Book Ratio	7.02	2.38	Medtronic plc
Debt-to-Equity Ratio	52.16	61.39	Boston Scientific
PEG Ratio	37.78	15.27	Medtronic plc
EV/EBITDA	34.73	14.85	Medtronic plc
Profit Margin (TTM)	13.55%	13.90%	Medtronic plc
Operating Margin (TTM)	20.27%	17.09%	Boston Scientific
EBITDA Margin (TTM)	20.27%	17.09%	Boston Scientific
Return on Equity	8.42%	9.51%	Medtronic plc
Return on Assets (TTM)	4.70%	4.41%	Boston Scientific
Free Cash Flow (TTM)	$2.37B	$5.19B	Medtronic plc
Dividend Yield	N/A	3.27%	N/A
1-Year Return	41.49%	9.61%	Boston Scientific
Price-to-Sales Ratio (TTM)	8.43	3.41	Medtronic plc
Enterprise Value	$167.16B	$135.36B	Boston Scientific
EV/Revenue Ratio	9.04	4.04	Medtronic plc
Gross Profit Margin (TTM)	68.84%	64.75%	Boston Scientific
Revenue per Share (TTM)	$13	$26	Medtronic plc
Earnings per Share (Diluted)	$1.68	$3.61	Medtronic plc
Beta (Stock Volatility)	0.68	0.82	Boston Scientific

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Boston Scientific vs Medtronic plc Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Boston Scientific	0.47%	-0.69%	0.60%	2.15%	2.27%	17.93%
Medtronic plc	-1.00%	-3.87%	0.66%	6.92%	-1.31%	11.37%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Boston Scientific	41.49%	157.47%	170.49%	509.66%	1,717.41%	267.54%
Medtronic plc	9.61%	-4.22%	-10.70%	15.31%	136.29%	66.34%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Boston Scientific (BSX): View Full Stock Overview

Medtronic plc (MDT): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Boston Scientific vs Medtronic plc

Metric	BSX	MDT
Market Information
Market Cap i	$155.95B	$114.47B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	7,790,150	6,273,350
90 Day Avg. Volume i	7,716,607	7,565,287
Last Close	$105.41	$89.34
52 Week Range	$71.88 - $108.94	$79.29 - $96.25
% from 52W High	-3.24%	-7.18%
All-Time High	$108.94 (Jul 23, 2025)	$135.89 (Sep 06, 2021)
% from All-Time High	-3.24%	-34.26%
Growth Metrics
Quarterly Revenue Growth	0.23%	0.04%
Quarterly Earnings Growth	1.46%	0.62%
Financial Health
Profit Margin (TTM) i	0.14%	0.14%
Operating Margin (TTM) i	0.20%	0.17%
Return on Equity (TTM) i	0.08%	0.10%
Debt to Equity (MRQ) i	52.16	61.39
Cash & Liquidity
Book Value per Share (MRQ)	$15.02	$37.46
Cash per Share (MRQ)	$0.49	$7.00
Operating Cash Flow (TTM) i	$2.97B	$7.04B
Levered Free Cash Flow (TTM) i	$4.17B	$4.21B
Dividends
Last 12-Month Dividend Yield i	N/A	3.27%
Last 12-Month Dividend i	N/A	$2.80

Valuation & Enterprise Metrics Analysis: Boston Scientific vs Medtronic plc

Metric	BSX	MDT
Price Ratios
P/E Ratio (TTM) i	62.74	24.75
Forward P/E i	37.78	15.27
PEG Ratio i	37.78	15.27
Price to Sales (TTM) i	8.43	3.41
Price to Book (MRQ) i	7.02	2.38
Market Capitalization
Market Capitalization i	$155.95B	$114.47B
Enterprise Value i	$167.16B	$135.36B
Enterprise Value Metrics
Enterprise to Revenue i	9.04	4.04
Enterprise to EBITDA i	34.73	14.85
Risk & Other Metrics
Beta i	0.68	0.82
Book Value per Share (MRQ) i	$15.02	$37.46

Financial Statements Comparison: Boston Scientific vs Medtronic plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BSX	MDT
Revenue/Sales i	$4.66B	$8.93B
Cost of Goods Sold i	$1.45B	$3.15B
Gross Profit i	$3.21B	$5.78B
Research & Development i	$443.00M	$684.00M
Operating Income (EBIT) i	$937.00M	$1.80B
EBITDA i	$1.23B	$2.64B
Pre-Tax Income i	$805.00M	$1.26B
Income Tax i	$133.00M	$199.00M
Net Income (Profit) i	$672.00M	$1.06B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BSX	MDT
Cash & Equivalents i	$725.00M	$2.22B
Total Current Assets i	$7.34B	$23.81B
Total Current Liabilities i	$5.06B	$12.88B
Long-Term Debt i	$10.93B	$25.64B
Total Shareholders Equity i	$22.45B	$48.26B
Retained Earnings i	$3.35B	$31.48B
Property, Plant & Equipment i	$448.00M	$7.16B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BSX	MDT
Operating Cash Flow i	$513.00M	$2.14B
Capital Expenditures i	$-187.00M	$-459.00M
Free Cash Flow i	$277.00M	$2.07B
Debt Repayment i	$-1.31B	N/A
Common Stock Repurchase i	N/A	$-274.00M

Short Interest & Institutional Ownership Analysis

Metric	BSX	MDT
Shares Short i	19.57M	13.07M
Short Ratio i	2.65	1.54
Short % of Float i	0.01%	0.01%
Average Daily Volume (10 Day) i	7,790,150	6,273,350
Average Daily Volume (90 Day) i	7,716,607	7,565,287
Shares Outstanding i	1.47B	1.28B
Float Shares i	1.48B	1.28B
% Held by Insiders i	0.00%	0.00%
% Held by Institutions i	0.94%	0.87%

Dividend Analysis & Yield Comparison: Boston Scientific vs Medtronic plc

Metric	BSX	MDT
Last 12-Month Dividend i	N/A	$2.80
Last 12-Month Dividend Yield i	N/A	3.27%
3-Year Avg Annual Dividend i	N/A	$2.76
3-Year Avg Dividend Yield i	N/A	0.83%
3-Year Total Dividends i	N/A	$8.28
Ex-Dividend Date	N/A	Mar 28, 2025

Boston Scientific [BSX] vs Medtronic plc [MDT] Detailed Stock Comparison